SK15142002A3 - Stabilná kryštalická forma derivátu tiazolidíndiónu a spôsob jej výroby - Google Patents

Stabilná kryštalická forma derivátu tiazolidíndiónu a spôsob jej výroby Download PDF

Info

Publication number
SK15142002A3
SK15142002A3 SK1514-2002A SK15142002A SK15142002A3 SK 15142002 A3 SK15142002 A3 SK 15142002A3 SK 15142002 A SK15142002 A SK 15142002A SK 15142002 A3 SK15142002 A3 SK 15142002A3
Authority
SK
Slovakia
Prior art keywords
crystals
krp
isopropyl alcohol
producing
same
Prior art date
Application number
SK1514-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Michiro Ohnota
Kazuo Orita
Original Assignee
Kyorin Pharmaceutical Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co., Ltd filed Critical Kyorin Pharmaceutical Co., Ltd
Publication of SK15142002A3 publication Critical patent/SK15142002A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1514-2002A 2000-04-25 2001-04-23 Stabilná kryštalická forma derivátu tiazolidíndiónu a spôsob jej výroby SK15142002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000124006 2000-04-25
PCT/JP2001/003450 WO2001081327A1 (fr) 2000-04-25 2001-04-23 Nouveau cristal stable de derive thiazolidinedione et son procede de production

Publications (1)

Publication Number Publication Date
SK15142002A3 true SK15142002A3 (sk) 2003-04-01

Family

ID=18634205

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1514-2002A SK15142002A3 (sk) 2000-04-25 2001-04-23 Stabilná kryštalická forma derivátu tiazolidíndiónu a spôsob jej výroby

Country Status (23)

Country Link
US (1) US6770133B2 (fr)
EP (1) EP1277745A4 (fr)
KR (1) KR20030007548A (fr)
CN (1) CN1426402A (fr)
AU (1) AU4882801A (fr)
BG (1) BG107200A (fr)
BR (1) BR0110258A (fr)
CA (1) CA2407349A1 (fr)
CZ (1) CZ20023502A3 (fr)
EA (1) EA004244B1 (fr)
EE (1) EE200200601A (fr)
HK (1) HK1053835A1 (fr)
HU (1) HUP0300475A3 (fr)
IL (1) IL152224A0 (fr)
IS (1) IS6586A (fr)
MA (1) MA25664A1 (fr)
MX (1) MXPA02010545A (fr)
NO (1) NO20025069L (fr)
PL (1) PL365533A1 (fr)
SK (1) SK15142002A3 (fr)
WO (1) WO2001081327A1 (fr)
YU (1) YU80302A (fr)
ZA (1) ZA200208293B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818776B2 (en) 2000-02-01 2004-11-16 Kyorin Pharmaceutical Co., Ltd. Alkali metal salt of thiazolidine-2,4-dione derivative
JPWO2003062214A1 (ja) * 2002-01-23 2005-05-19 杏林製薬株式会社 ベンジルチアゾリジンジオン誘導体の新規な安定結晶とその製法
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
RU2422450C2 (ru) 2003-11-19 2011-06-27 Метабазис Терапеутикс, Инк. Новые фосфорсодержащие тиромиметики
DE602004004631D1 (de) 2004-04-01 2007-03-22 Sanofi Aventis Deutschland Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
TWI383008B (zh) * 2005-08-17 2013-01-21 Nippon Catalytic Chem Ind 吸水性樹脂之製造方法及吸水性樹脂以及其利用
TW200838512A (en) 2007-02-08 2008-10-01 Daiichi Sankyo Co Ltd Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864028A (en) * 1983-09-14 1989-09-05 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
JPH04270273A (ja) 1991-02-25 1992-09-25 Kyorin Pharmaceut Co Ltd チアゾリジン−2,4−ジオン誘導体とその塩及びその製造法
JP3053490B2 (ja) 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−2,4−ジオン誘導体とその塩及び製造法
JP3644998B2 (ja) 1995-02-09 2005-05-11 塩野義製薬株式会社 ベンジリデン誘導体の結晶の選択的取得方法
US6147101A (en) * 1995-06-02 2000-11-14 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
US6001862A (en) * 1995-06-02 1999-12-14 Kyorin Pharameuticals Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 N−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
ZA971637B (en) * 1996-02-28 1997-09-25 Nissan Chemical Ind Ltd Thifluzamide with improved efficacy.
JPH101476A (ja) 1996-02-28 1998-01-06 Nissan Chem Ind Ltd 効力が向上したチフルザミド
GB9726566D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
BR0110258A (pt) 2003-01-07
US6770133B2 (en) 2004-08-03
EA200201055A1 (ru) 2003-06-26
HUP0300475A3 (en) 2004-10-28
CZ20023502A3 (cs) 2003-06-18
IS6586A (is) 2002-10-21
ZA200208293B (en) 2003-10-06
NO20025069D0 (no) 2002-10-22
EA004244B1 (ru) 2004-02-26
HUP0300475A2 (hu) 2003-06-28
BG107200A (bg) 2003-11-28
MXPA02010545A (es) 2004-05-14
EP1277745A4 (fr) 2004-09-15
US20030101925A1 (en) 2003-06-05
IL152224A0 (en) 2003-05-29
CN1426402A (zh) 2003-06-25
HK1053835A1 (zh) 2003-11-07
WO2001081327A1 (fr) 2001-11-01
CA2407349A1 (fr) 2002-10-24
NO20025069L (no) 2002-10-22
EP1277745A1 (fr) 2003-01-22
KR20030007548A (ko) 2003-01-23
MA25664A1 (fr) 2002-12-31
YU80302A (sh) 2005-11-28
AU4882801A (en) 2001-11-07
EE200200601A (et) 2004-04-15
PL365533A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
SK15142002A3 (sk) Stabilná kryštalická forma derivátu tiazolidíndiónu a spôsob jej výroby
CN104910049B (zh) Azd9291中间体及其制备方法
PL161379B1 (pl) S p o só b wytwarzania kwasu 2-[2-[4-[/4-chlorofenylo/fenylom etylo]-1-piperazynylo] etoksy]octow ego i jego dichlorowodorku PL PL
JPS59227870A (ja) 新規2−グアニジノチアゾリン誘導体ならびにその製造法
KR20060052532A (ko) 히드록시나프토산 히드라지드 화합물 및 그의 제조 방법
SE452610B (sv) Sett att spalta racemiska cis-1,2-cyklopropandikarboxylsyraderivat
SU1340585A3 (ru) Способ получени производных тетразола
KR100735711B1 (ko) 형광 증백제 및 이의 합성방법
Zupet et al. Some transformations of alkyl heteroarylpyruvates
JPS6363658A (ja) 置換インドリノン誘導体の製造法
CA1126280A (fr) Derives de benzimidazole et de benzimidazolidine, agissant comme diuretique et antihypertenseur
JPS63502903A (ja) 治療学的抗潰瘍活性を有する化合物の合成方法
Kasimogullari et al. Synthesis of new derivatives of 1-(3-amino-phenyl)-4-benzoyl-5-phenyl-1h-pyrazole-3-carboxylic acid
JP4105821B2 (ja) ジアゾ化合物
SU1072804A3 (ru) Способ получени производных тиазола
JPWO2003062214A1 (ja) ベンジルチアゾリジンジオン誘導体の新規な安定結晶とその製法
CN110878045A (zh) 一种化合物及其制备方法和应用
KR100277510B1 (ko) 테트라하이드로카르바졸론 유도체의 제조방법
JP4299895B2 (ja) ベンゾ[b] チオフェン−2, 3−ジオン−2− オキシム誘導体およびその製法ならびにそれを用いた1,2,3−ベンゾチアジアゾール−7− カルボン酸の製法
WO2001005775A1 (fr) Procede de preparation de composes benzisothiazole substitues
JPH1112254A (ja) 3−(3−ピリジルメチルアミノ)−3,4−ジヒドロ−2(1h)−キナゾリノン誘導体及びその中間体の製造方法
JPH03188070A (ja) アミノトリアジン誘導体の製造方法
JPS6320429B2 (fr)
EP0433879A2 (fr) Aminothiazoles
JPS63287755A (ja) アントラニル酸エステルの製造方法